Identity
HGNC
LOCATION
22q11.21
LOCUSID
ALIAS
ARC105,CAG7A,CTG7A,PCQAP,TIG-1,TIG1,TNRC7
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 51586
MIM: 607372
HGNC: 14248
Ensembl: ENSG00000099917
Variants:
dbSNP: 51586
ClinVar: 51586
TCGA: ENSG00000099917
COSMIC: MED15
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36997032 | 2023 | Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. | 1 |
| 36997032 | 2023 | Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. | 1 |
| 33772081 | 2021 | MED15 prion-like domain forms a coiled-coil responsible for its amyloid conversion and propagation. | 6 |
| 33904398 | 2021 | Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator. | 55 |
| 33772081 | 2021 | MED15 prion-like domain forms a coiled-coil responsible for its amyloid conversion and propagation. | 6 |
| 33904398 | 2021 | Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator. | 55 |
| 32439976 | 2020 | MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. | 3 |
| 32439976 | 2020 | MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. | 3 |
| 31828108 | 2019 | A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion. | 3 |
| 31828108 | 2019 | A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion. | 3 |
| 29400661 | 2018 | The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma. | 7 |
| 29400661 | 2018 | The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma. | 7 |
| 27974704 | 2017 | MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling. | 11 |
| 27974704 | 2017 | MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling. | 11 |
| 25791637 | 2015 | Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma. | 12 |
Citation
Dessen P
MED15 (mediator complex subunit 15)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/43823/med15-(mediator-complex-subunit-15)
